
Outlook Therapeutics, Inc.
USD1.69
-0.02 (-1.17%)
CEO
Robert Charles Jahr
IPO Date
2016-06-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.72
Prev. Close
$1.71
Day Low
$1.62
Day High
$1.77
52W Low
$0.16
52W High
$3.39
Market Cap
$0.07B
Volume
7.73M
| 18 Feb 2026 |
| HC Wainwright & Co. |
| Neutral |
| Neutral |
| maintain |
| 18 Feb 2026 | Chardan Capital | Neutral | Neutral | maintain |
| 5 Jan 2026 | Chardan Capital | Neutral | Neutral | maintain |
| 2 Jan 2026 | HC Wainwright & Co. | Neutral | Neutral | maintain |
| 22 Dec 2025 | Ascendiant Capital | Buy | Buy | maintain |
| 30 Sept 2025 | HC Wainwright & Co. | Neutral | Neutral | maintain |
| 22 Sept 2025 | Ascendiant Capital | Buy | Buy | maintain |